1721 related articles for article (PubMed ID: 22487856)
1. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
Nelson PT; Alafuzoff I; Bigio EH; Bouras C; Braak H; Cairns NJ; Castellani RJ; Crain BJ; Davies P; Del Tredici K; Duyckaerts C; Frosch MP; Haroutunian V; Hof PR; Hulette CM; Hyman BT; Iwatsubo T; Jellinger KA; Jicha GA; Kövari E; Kukull WA; Leverenz JB; Love S; Mackenzie IR; Mann DM; Masliah E; McKee AC; Montine TJ; Morris JC; Schneider JA; Sonnen JA; Thal DR; Trojanowski JQ; Troncoso JC; Wisniewski T; Woltjer RL; Beach TG
J Neuropathol Exp Neurol; 2012 May; 71(5):362-81. PubMed ID: 22487856
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.
Nelson PT; Jicha GA; Schmitt FA; Liu H; Davis DG; Mendiondo MS; Abner EL; Markesbery WR
J Neuropathol Exp Neurol; 2007 Dec; 66(12):1136-46. PubMed ID: 18090922
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.
Nelson PT; Braak H; Markesbery WR
J Neuropathol Exp Neurol; 2009 Jan; 68(1):1-14. PubMed ID: 19104448
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
Purohit DP; Perl DP; Haroutunian V; Powchik P; Davidson M; Davis KL
Arch Gen Psychiatry; 1998 Mar; 55(3):205-11. PubMed ID: 9510214
[TBL] [Abstract][Full Text] [Related]
6. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
7. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
[TBL] [Abstract][Full Text] [Related]
8. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
Bennett DA; Schneider JA; Wilson RS; Bienias JL; Arnold SE
Arch Neurol; 2004 Mar; 61(3):378-84. PubMed ID: 15023815
[TBL] [Abstract][Full Text] [Related]
9. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
11. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological changes in aging brain.
Xekardaki A; Kövari E; Gold G; Papadimitropoulou A; Giacobini E; Herrmann F; Giannakopoulos P; Bouras C
Adv Exp Med Biol; 2015; 821():11-7. PubMed ID: 25416106
[TBL] [Abstract][Full Text] [Related]
13. Pathological substrates of cognitive decline in Alzheimer's disease.
Giannakopoulos P; Gold G; von Gunten A; Hof PR; Bouras C
Front Neurol Neurosci; 2009; 24():20-29. PubMed ID: 19182459
[TBL] [Abstract][Full Text] [Related]
14. Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.
Serrano-Pozo A; Qian J; Monsell SE; Frosch MP; Betensky RA; Hyman BT
J Neuropathol Exp Neurol; 2013 Dec; 72(12):1182-92. PubMed ID: 24226270
[TBL] [Abstract][Full Text] [Related]
15. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes.
Gómez-Isla T; Frosch MP
Nat Rev Neurol; 2022 Jun; 18(6):323-332. PubMed ID: 35332316
[TBL] [Abstract][Full Text] [Related]
16. Neuropathologic features of amnestic mild cognitive impairment.
Petersen RC; Parisi JE; Dickson DW; Johnson KA; Knopman DS; Boeve BF; Jicha GA; Ivnik RJ; Smith GE; Tangalos EG; Braak H; Kokmen E
Arch Neurol; 2006 May; 63(5):665-72. PubMed ID: 16682536
[TBL] [Abstract][Full Text] [Related]
17. Pathology of clinical and preclinical Alzheimer's disease.
Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
[TBL] [Abstract][Full Text] [Related]
18. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
Luan K; Rosales JL; Lee KY
Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
[TBL] [Abstract][Full Text] [Related]
19. Divergent cognitive status with the same Braak stage of neurofibrillary pathology: does the pattern of amyloid-β deposits make the difference?
Maderna E; Cattaneo C; Cacciatore F; Catania M; Di Fede G; Tagliavini F; Giaccone G
J Alzheimers Dis; 2015; 43(2):375-9. PubMed ID: 25096620
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.
Fleisher AS; Pontecorvo MJ; Devous MD; Lu M; Arora AK; Truocchio SP; Aldea P; Flitter M; Locascio T; Devine M; Siderowf A; Beach TG; Montine TJ; Serrano GE; Curtis C; Perrin A; Salloway S; Daniel M; Wellman C; Joshi AD; Irwin DJ; Lowe VJ; Seeley WW; Ikonomovic MD; Masdeu JC; Kennedy I; Harris T; Navitsky M; Southekal S; Mintun MA;
JAMA Neurol; 2020 Jul; 77(7):829-839. PubMed ID: 32338734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
